| Date Filed | Type | Description |
| 10/03/2023 |
4
| Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 346 shares
@ $59.92, valued at
$20.7k
|
|
| 09/26/2023 |
4
| Zimmermann Martine (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 2,285 shares
@ $0
Granted 11,345 options to buy
@ $59.08, valued at
$670.3k
|
|
| 08/14/2023 |
4
| Reardon Andrew (CHIEF LEGAL OFFICER &) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 897 shares
@ $68.73, valued at
$61.7k
|
|
| 07/10/2023 |
4
| Korenberg Matthew E (PRESIDENT & CHIEF OPERATING) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Acquired 376 shares
@ $56.78, valued at
$21.3k
|
|
| 07/10/2023 |
4
| Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Acquired 375 shares
@ $56.78, valued at
$21.3k
|
|
| 05/18/2023 |
4
| KOZARICH JOHN W (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 4,444 shares
@ $77.2009, valued at
$343.1k
|
|
| 05/10/2023 |
4
| KOZARICH JOHN W (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 5,819 shares
@ $76.511, valued at
$445.2k
Sold 589 shares
@ $77.0974, valued at
$45.4k
Exercised 6,408 options to buy
@ $18.82, valued at
$120.6k
|
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2023 |
4
| Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 6,046 shares
@ $0
Granted 16,419 options to buy
@ $75.09, valued at
$1.2M
|
|
| 02/27/2023 |
4
| Korenberg Matthew E (President & COO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 9,069 shares
@ $0
Granted 24,628 options to buy
@ $75.09, valued at
$1.8M
|
|
| 02/27/2023 |
4
| Reardon Andrew (See Remarks) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 5,668 shares
@ $0
Granted 15,393 options to buy
@ $75.09, valued at
$1.2M
|
|
| 02/27/2023 |
4
| Davis Todd C (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 17,005 shares
@ $0
Granted 46,178 options to buy
@ $75.09, valued at
$3.5M
|
|
| 01/04/2023 |
4
| Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Acquired 275 shares
@ $56.78, valued at
$15.6k
|
|
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2022 |
4
| HIGGINS JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 92,932 options to buy
@ $67.03, valued at
$6.2M
|
|
| 12/27/2022 |
4
| Korenberg Matthew E (President & COO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 25,967 options to buy
@ $67.03, valued at
$1.7M
|
|
| 12/27/2022 |
4
| KOZARICH JOHN W (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 6,623 options to buy
@ $67.03, valued at
$443.9k
|
|
| 12/27/2022 |
4
| Gray Nancy Ryan (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 3,050 options to buy
@ $67.03, valued at
$204.4k
|
|
| 12/27/2022 |
4
| Sabba Stephen L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 6,623 options to buy
@ $67.03, valued at
$443.9k
|
|
| 12/27/2022 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 4,484 options to buy
@ $67.03, valued at
$300.6k
|
|
| 12/27/2022 |
4
| Aryeh Jason (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 4,484 options to buy
@ $67.03, valued at
$300.6k
|
|
| 12/27/2022 |
4
| Davis Todd C (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 2,081 options to buy
@ $67.03, valued at
$139.5k
|
|
| 12/27/2022 |
4
| Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 6,620 options to buy
@ $67.03, valued at
$443.7k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|